Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment
Recruiting
Observational Study
Liver Cancer (Primary and Metastatic)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 800 (estimated)
- Sponsor
- Tongji Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is a prospective, observational, real-world cohort study. We aim to establish a prospective database in the Department of Hepatobiliary and Pancreatic Surgery, systematically collecting and integrating patients' full-course diagnostic and therapeutic information along with long-term outcomes. This will enable objective evaluation of prognosis and treatment efficacy in real-world clinica…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male or female aged ≥18 years at the time of signing the informed consent form
* Clinically or histologically confirmed diagnosis of liver cancer
* Recieving treatment and follow-up in Tongji Hospital
Exclusion Criteria:
\- Refuse participanting in this study
Contacts